/biz/ - Business & Finance

>>56869421
>Look for stuff with 14-21 days until FDA deadline
>Phase 3 is likely to succeed, Phase 1-2 are the risky ones
>Buy or sell whatever with good position sizing and risk management
https://www.fdatracker.com/fda-calendar/

The tricky part for me was setting my stops correctly. Biotechs have the random fuckyou candles, so I was doing 1% risk, but had it so that I did half the usual position size, but 2x the SL. This was all well and good, but when the upsides happened, it just didn't have enough size to really push me profitable. About 60% of my losses came from transaction fees.

This was just naive longs for the most part, but with a few technicals you could probably ignore flat trades and get slightly better timing, and also go short. I was also doing ATR/sector hedges with long positions in both LABU and LABD (broken charges txn fees on etfs only when I sell them). Overall I feel like I could navigate it somewhat better this time, but I want to wait until 2024 and tweak things a bit